This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, J B Articles by Levinson, A D Search for Related Content PubMed PubMed Citation Articles by Cohen, J B Articles by Levinson, A D

U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing.

Department of Cell Genetics, Genentech, Inc., South San Francisco, California 94080.

ABSTRACT

Pre-mRNA 5' splice site activity depends, at least in part, on base complementarity to U1 small nuclear RNA. In transient coexpression assays, defective 5' splice sites can regain activity in the presence of U1 carrying compensatory changes, but it is unclear whether such mutant U1 RNAs can be permanently expressed in mammalian cells. We have explored this issue to determine whether U1 small nuclear RNAs with altered specificity may be of value to rescue targeted mutant genes or alter pre-mRNA processing profiles. This effort was initiated following our observation that U1 with specificity for a splice site associated with an alternative H-ras exon substantially reduced the synthesis of the potentially oncogenic p21ras protein in transient assays. We describe the development of a mammalian complementation system that selects for removal of a splicing-defective intron placed within a drug resistance gene. Complementation was observed in proportion to the degree of complementarity between transfected mutant U1 genes and different defective splice sites, and all cells selected in this manner were found to express mutant U1 RNA. In addition, these cells showed specific activation of defective splice sites presented by an unlinked reporter gene. We discuss the prospects of this approach to permanently alter the expression of targeted genes in mammalian cells.

This article has been cited by other articles:

• Zahler, A. M., Tuttle, J. D., Chisholm, A. D. (2004). Genetic Suppression of Intronic +1G Mutations by Compensatory U1 snRNA Changes in Caenorhabditis elegans. Genetics 167: 1689-1696 [Abstract] [Full Text]  
• Fortes, P., Cuevas, Y., Guan, F., Liu, P., Pentlicky, S., Jung, S. P., Martinez-Chantar, M. L., Prieto, J., Rowe, D., Gunderson, S. I. (2003). Inhibiting expression of specific genes in mammalian cells with 5' end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proc. Natl. Acad. Sci. USA 100: 8264-8269 [Abstract] [Full Text]  
• Guil, S., Gattoni, R., Carrascal, M., Abian, J., Stevenin, J., Bach-Elias, M. (2003). Roles of hnRNP A1, SR Proteins, and p68 Helicase in c-H-ras Alternative Splicing Regulation. Mol. Cell. Biol. 23: 2927-2941 [Abstract] [Full Text]  
• Beckley, S. A., Liu, P., Stover, M. L., Gunderson, S. I., Lichtler, A. C., Rowe, D. W. (2001). Reduction of Target Gene Expression by a Modified U1 snRNA. Mol. Cell. Biol. 21: 2815-2825 [Abstract] [Full Text]  
• McCullough, A. J., Berget, S. M. (2000). An Intronic Splicing Enhancer Binds U1 snRNPs To Enhance Splicing and Select 5' Splice Sites. Mol. Cell. Biol. 20: 9225-9235 [Abstract] [Full Text]  
• Pret, A.-M., Fiszman, M. Y. (1996). Sequence Divergence Associated with Species-specific Splicing of the Nonmuscle beta-Tropomyosin Alternative Exon. J. Biol. Chem. 271: 11511-11517 [Abstract] [Full Text]  
• Hwang, D Y, Cohen, J B (1996). U1 snRNA promotes the selection of nearby 5' splice sites by U6 snRNA in mammalian cells.. Genes Dev. 10: 338-350 [Abstract]  
• Gorman, L., Mercatante, D. R., Kole, R. (2000). Restoration of Correct Splicing of Thalassemic beta -Globin Pre-mRNA by Modified U1 snRNAs. J. Biol. Chem. 275: 35914-35919 [Abstract] [Full Text]